Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Tag Archives: Prostate cancer
Aspirin Reduces Mortality in Prostate Cancer
In the Chinese Medicine, the cause of cancer is thought to be associated with the dysfunction of the coagulation system. Now, a study presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) has confirmed this … Continue reading
Posted in Cancer, Prostate cancer
Tagged Aspirin, Clexane, clopidogrel, coagulation, Coumadin, Enoxaparin, Lovenox, Mortality, Plavix, Prostate cancer, Warfarin
Comments Off on Aspirin Reduces Mortality in Prostate Cancer
Novel Agent Significantly Improves Survival in Men with Advanced Prostate Cancer
Great news for patients with advanced prostate cancer. A new investigational agent, abiraterone acetate, was shown to significantly improved survival in men with metastatic castration-resistant prostate cancer. Abiraterone acetate is an investigational agent being developed by Ortho Biotech. It acts … Continue reading
Posted in Cancer, Prostate cancer
Tagged abiraterone, androgen, castration-resistant, CYP17, docetaxel, Ortho Biotech, prednisone, Prostate cancer, Survival
Comments Off on Novel Agent Significantly Improves Survival in Men with Advanced Prostate Cancer
New Chemotherapy, Cabazitaxel (Jevtana), for Advanced Prostate Cancer
A new chemotherapy, Cabazitaxel (Jevtana) has been approved in the United States to treat men who have advanced hormone-refractory prostate cancer and have failed docetaxel. The approval was based on the results of the phase 3 TROPIC clinical study, which … Continue reading
Posted in Cancer, Prostate cancer
Tagged cabazitaxel, chemotherapy, hormone refractory, Jevtana, mitoxantrone, Prostate cancer, Survival, TROPIC
Comments Off on New Chemotherapy, Cabazitaxel (Jevtana), for Advanced Prostate Cancer
Psoriasis Is Associated With an Increased Risk of Cancer
If you have psoriasis, you might have an increased risk of cancer, including melanoma, prostate cancer and non-Hodgkin’s lymphoma, according to a new research presented at the 68th annual meeting of the American Academy of Dermatology (AAD 2010). The researchers … Continue reading
Posted in Breast cancer, Cancer, Lymphoma, Melanoma, Non-Hodgkin's Disease, Prostate cancer, Psoriasis
Tagged Breast cancer, Lymphoma, Melanoma, Non-Hodgkin's Disease, Prostate cancer, Psoriasis
Comments Off on Psoriasis Is Associated With an Increased Risk of Cancer
New Drug Offer Hope to Patients with Late Stage Prostate Cancer
At present, metastatic and hormonal-refractory prostate cancer patients who have failed 1st line chemotherapy will be given mitoxantrone plus prednisone as the salvage therapy. However, mitoxantrone plus prednisone is not very effective in controlling metastatic prostate cancer. Now, a new … Continue reading
Posted in Cancer, Prostate cancer
Tagged chemotherapy, Prostate cancer, Survival
Comments Off on New Drug Offer Hope to Patients with Late Stage Prostate Cancer
